F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells

Drug resistance remains a major clinical obstacle to successful treatment of cancer. As posttranslational modification is becoming widely recognized to affect the function of oncoproteins, targeting specific posttranslational protein modification provides an attractive strategy for anticancer drug d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bo, Liu, Zhen-Yu, Cui, Jian, Yang, Xiang-Min, Jing, Lin, Zhou, Yang, Chen, Zhi-Nan, Jiang, Jian-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297841/
https://www.ncbi.nlm.nih.gov/pubmed/28117675
http://dx.doi.org/10.3390/ijms18010212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297841/
https://www.ncbi.nlm.nih.gov/pubmed/28117675
http://dx.doi.org/10.3390/ijms18010212

Ejemplares similares